Phio Pharmaceuticals Corp (PHIO): Next-Year EPS Estimate 37.45%
As of 2026-06-11, Phio Pharmaceuticals Corp (PHIO) has a next-year EPS growth estimate of 37.45%.
On 2026-05-11, analyst consensus for PHIO's next-year EPS growth shifted from 35.27% to 37.45% — a positive change of 2.18 percentage points. The revised estimate has been sustained across 24 subsequent trading sessions. Current-year growth is projected at 5.17%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 37.45%
- EPS growth this year
- 5.17%
- EPS next quarter (est)
- -$0.36
- Last price
- $1.08
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 37.45% | 5.17% | -$0.36 | $1.08 |
| 2026-06-10 | 37.45% | 5.17% | -$0.36 | $1.06 |
| 2026-06-09 | 37.45% | 5.17% | -$0.36 | $1.08 |
| 2026-06-08 | 37.45% | 5.17% | -$0.36 | $1.09 |
| 2026-06-07 | 37.45% | 5.17% | -$0.36 | $1.06 |
| 2026-06-04 | 37.45% | 5.17% | -$0.36 | $1.14 |
| 2026-06-03 | 37.45% | 5.17% | -$0.36 | $1.11 |
| 2026-06-02 | 37.45% | 5.17% | -$0.36 | $1.12 |
| 2026-06-01 | 37.45% | 5.17% | -$0.36 | $1.13 |
| 2026-05-31 | 37.45% | 5.17% | -$0.36 | $1.11 |
| 2026-05-28 | 37.45% | 5.17% | -$0.34 | $1.14 |
| 2026-05-27 | 37.45% | 5.17% | -$0.34 | $1.10 |
| 2026-05-26 | 37.45% | 5.17% | -$0.34 | $1.08 |
| 2026-05-25 | 37.45% | 5.17% | -$0.34 | $1.09 |
| 2026-05-24 | 37.45% | 5.17% | -$0.34 | $1.09 |
| 2026-05-21 | 37.45% | 5.17% | -$0.34 | $1.09 |
| 2026-05-20 | 37.45% | 5.17% | -$0.34 | $1.08 |
| 2026-05-19 | 37.45% | 5.17% | -$0.34 | $1.06 |
| 2026-05-18 | 37.45% | 5.17% | -$0.34 | $1.08 |
| 2026-05-17 | 37.45% | 5.17% | -$0.34 | $1.07 |
| 2026-05-14 | 37.45% | 5.17% | -$0.34 | $1.12 |
| 2026-05-13 | 37.45% | 5.17% | -$0.34 | $1.15 |
| 2026-05-12 | 37.45% | 5.17% | -$0.34 | $1.10 |
| 2026-05-11 | 37.45% | 5.17% | -$0.34 | $1.08 |
| 2026-05-10 | 35.27% | 16.90% | -$0.28 | $1.07 |
| 2026-05-07 | 34.74% | 34.48% | -$0.23 | $1.14 |
| 2026-05-06 | 34.74% | 34.48% | -$0.23 | $1.15 |
| 2026-05-05 | 34.74% | 34.48% | -$0.23 | $1.13 |
| 2026-05-04 | 34.74% | 34.48% | -$0.23 | $1.16 |
| 2026-05-03 | 34.74% | 34.48% | -$0.23 | $1.14 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Phio Pharmaceuticals Corp's next-year EPS growth estimate?▾
As of 2026-06-11, Phio Pharmaceuticals Corp (PHIO) has a next-year EPS growth estimate of 37.45%, based on analyst consensus.
When was the latest EPS estimate revision for PHIO?▾
The most recent revision occurred on 2026-05-11, when analysts adjusted the next-year EPS growth estimate from 35.27% to 37.45%.
What sector and industry does Phio Pharmaceuticals Corp belong to?▾
Phio Pharmaceuticals Corp operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. PHIO appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Phio Pharmaceuticals Corp (PHIO) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports